【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 11
2 Neurodegenerative Diseases Market to 2018: Introduction 13
3 Neurodegenerative Diseases Market to 2018: Global Market Overview 14
3.1 Revenue 14
3.2 Treatment Usage Pattern 16
3.3 Distribution by Market 17
3.4 Drivers and Restraints of the Neurodegenerative Diseases Market 18
3.4.1 Drivers 18
3.4.2 Restraints 18
4 Therapeutic Landscape 19
4.1 Market for Alzheimer’s Disease 19
4.1.1 Introduction 19
4.1.2 Revenue and Forecasts 21
4.1.3 Treatment Usage Pattern 23
4.1.4 Geographical Landscape 24
4.1.5 Drivers and Restraints for the Alzheimer’s Disease Market 46
4.2 Market for Parkinson’s Disease 47
4.2.1 Introduction 47
4.2.2 Revenue and Forecasts 49
4.2.3 Treatment Usage Pattern 50
4.2.4 Geographical Landscape 51
4.2.5 Drivers and Restraints for the Parkinson’s Disease Market 73
4.3 Market for Amyotrophic Lateral Sclerosis 74
4.3.1 Introduction 74
4.3.2 Revenue and Forecasts 76
4.3.3 Treatment Usage Pattern 77
4.3.4 Geographical Landscape 78
4.3.5 Drivers and Restraints for the Amyotrophic Lateral Sclerosis Market 100
4.4 Market for Huntington’s Disease 101
4.4.1 Introduction 101
4.4.2 Revenue and Forecasts 103
4.4.3 Treatment Usage Pattern 104
4.4.4 Geographical Landscape 105
4.4.5 Drivers and Restraints for the Huntington’s Disease Market 127
5 Neurodegenerative Diseases Market: Pipeline Analysis 128
5.1 Introduction 128
5.2 Summary of the Current Neurodegenerative Diseases R&D Pipeline 129
5.2.1 Alzheimer’s Disease 129
5.2.2 Amyotrophic Lateral Sclerosis 142
5.2.3 Parkinson’s Disease 147
5.2.4 Huntington’s Disease 155
6 Neurodegenerative Diseases Market: Deals and Strategic Consolidations 158
6.1 Merger and Acquisition Deals 158
6.1.1 Sanofi-Synthelabo Merges with Aventis 160
6.1.2 Bayer Acquires Schering 160
6.1.3 Takeda Pharma Completes Acquisition of Nycomed International for $13,681m 160
6.1.4 Teva Pharma Acquires Ivax 160
6.1.5 Abbott Labs Acquires Solvay Pharma 160
6.1.6 Teva Completes Acquisition of Cephalon for $6.8 billion 160
6.1.7 UCB Acquires 87.62% Stake in Schwarz Pharma 161
6.1.8 Biovail Acquires Valeant Pharma 161
6.1.9 Dainippon Sumitomo Pharma Completes Acquisition of Sepracor for $2.6 Billion 161
6.1.10 Merck Acquires Banyu Pharma 161
6.1.11 Amgen Completes Acquisition of Micromet for $1.2 Billion 161
6.1.12 Bayer Acquires Minority Stake in Bayer Schering Pharma 161
6.1.13 Daiichi Sankyo Completes Acquisition of Plexxikon 162
6.1.14 Lundbeck Acquires Ovation Pharma 162
6.1.15 Eli Lilly and Company Acquires Avid RadioPharma 162
6.1.16 Abbott Labs Completes Acquisition of Facet Biotech 162
6.1.17 Biogen Idec Acquires Fumapharm 162
6.1.18 Upsher-Smith Completes Acquisition of Remaining 84% Stake in Proximagen for up to $555m 163
6.1.19 Sun Pharma Acquires Controlling Stake in Taro Pharma 163
6.1.20 Pfizer Acquires Rinat Neuroscience 163
6.1.21 Cubist Pharma Completes Acquisition of Adolor for $415m 163
6.1.22 Biogen Idec Acquires Panima Pharma 164
6.1.23 Teva Pharma Acquires CoGenesys from New Enterprise, Orbimed and Red Abbey 164
6.1.24 Fujifilm Holdings Acquires 66% Stake in Toyama Chemical 164
6.1.25 MGI PHARMA Acquires Guilford Pharma 164
6.1.26 H. Lundbeck Acquires LifeHealth 164
6.1.27 Endo Pharma Completes Acquisition of Penwest Pharma 165
6.1.28 EPIX Pharma Acquires Predix Pharma 165
6.1.29 Biogen Idec Acquires Syntonix Pharmaceuticals 165
6.1.30 Biotie Therapies Acquires Synosia Therapeutics 165
6.2 Licensing Agreements 166
6.2.1 Cephalon Enters into a Licensing Agreement with Mesoblast for Regenerative Medicine 167
6.2.2 Idera Pharma Enters into a Licensing Agreement with Merck 167
6.2.3 Astellas Pharma Enters into Licensing Agreement with CoMentis for Beta-Secretase Inhibitors 167
6.2.4 Synosia Therapeutics Enters into Licensing Agreement with UCB for SYN-115 and SYN-118 167
6.2.5 GlaxoSmithKline Signs an Agreement with AFFiRiS 168
6.2.6 Biogen Enters into an Agreement with Acorda Therapeutics 168
6.2.7 BioMS Medical Enters into Licensing Agreement with Eli Lilly 168
6.2.8 AC Immune Enters into Licensing Agreement with Genentech for Anti-Tau Antibodies 168
6.2.9 Biovail Enters into Licensing Agreement with Acadia Pharmaceuticals 168
6.2.10 Biogen Idec Enters into Licensing Agreement with Knopp Neurosciences for KNS-760704 169
6.2.11 AstraZeneca Enters into Licensing Agreement with Targacept 169
6.2.12 AC Immune Enters into Licensing Agreement with Genentech 169
6.2.13 Proximagen Enters into Licensing Agreement with Upsher-Smith Labs 169
6.2.14 Merck Serono Enters into Licensing Agreement with Apitope Technology 170
6.2.15 Serono Enters into Licensing Agreement with Newron Pharma for Safinamide 170
6.2.16 Shire Exercises Option to License Adenosine A2A from Heptares Therapeutics 170
6.2.17 GlaxoSmithKline Enters into Licensing Agreement with Impax Pharma for IPX066 170
6.2.18 Santhera Pharmaceuticals Enters into Licensing Agreement with Ipsen for Fipamezole 171
6.2.19 Domain Therapeutics Enters into Licensing Agreement with Merck Serono 171
6.2.20 Addex Pharma Enters into Collaboration and Licensing Agreement with Merck & Co 171
6.2.21 Curis Enters into Licensing Agreement with Wyeth Pharma 171
6.2.22 Pfizer Enters into a License and Collaboration Agreement with Transtech Pharma 171
6.2.23 Antisense Therapeutics Enters into Licensing Agreement with Teva Pharma 172
6.2.24 Biogen Idec Enters into Licensing Agreement with Vernalis 172
6.3 Co-Development Deals 173
6.3.1 GlaxoSmithKline Signs an Agreement with Targacept 174
6.3.2 GlaxoSmithKline Enters into an Agreement with EPIX Pharma 174
6.3.3 Evotec Enters into Co-Development Agreement with Roche 174
6.3.4 Pfizer Enters into Co-Development Agreement with Medivation for Dimebon 174
6.3.5 Alectos Therapeutics Enters into Research Collaboration with Merck & Co 174
6.3.6 Targacept Expands its Collaboration Agreement with AstraZeneca 175
6.3.7 Boehringer Ingelheim Partners with Vitae Pharma 175
6.3.8 Elan Enters into Co-Development Agreement with Transition Therapeutics 175
6.3.9 Ceregene Enters into Agreement with Genzyme 175
7 Appendix 176
7.1 Market Definitions 176
7.2 Abbreviations 176
7.3 Sources 177
7.4 Research Methodology 179
7.4.1 Coverage 180
7.4.2 Secondary Research 180
7.4.3 Primary Research 180
7.5 Therapeutic Landscape 181
7.5.1 Epidemiology-based Forecasting 181
7.5.2 Market Size by Geography 182
7.6 Geographical Landscape 183
7.7 Pipeline Analysis 184
7.8 Competitive Landscape 184
7.8.1 Expert Panel Validation 184
7.9 Contact Us 184
7.10 Disclaimer 184
【レポート販売概要】
■ タイトル:Neurodegenerative Diseases Market to 2018 – New Product Entries in both Niche and Broader Parkinson’s Disease Treatment will Boost Market Despite Patent Cliff■ 発行日:2013年3月20日
■ 調査会社:GBI Research
■ 商品コード:GBIR403170051
■ 調査対象地域:グローバル
- Comprehensive MVNO/MVNE PackageThis package is simply the most comprehensive package available in the market. It includes a real MVNO Business Plan from an actual launch plan. It includes a complete pre-paid MVNO business plan with information to support planning needs while easy to modify to reflect different strategies. It also includes a fully functional MVNO Business Plan Spreadsheet (in Excel) enabling financial forecastin …
- ワイヤレス・コネクティビティ(無線通信)の世界市場予測(~2022)The wireless connectivity market, in terms of value, is expected to grow from USD 14.84 Billion in 2015 to USD 24.69 Billion by 2022, at a CAGR of 7.6% between 2016 and 2022. The wireless connectivity market is highly diversified and competitive with market players including top-tier and mid-tier companies as well as start-up firms. With the rate of proliferation of smart sensors, the increasing a …
- Kodiak Oil & Gas Corp.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Kodiak Oil & Gas Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Kodiak Oil & Gas Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- Norwegian Energy Company ASA:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Norwegian Energy Company ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Norwegian Energy Company ASA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
- 3Dスキャンの世界市場分析:製品別(レーザースキャナー、構造化ライトスキャナー、光学スキャナー)、範囲別(小範囲、中範囲、広範囲)、用途別、セグメント予測、2014-2025The global 3D scanning market is expected to reach USD 8.04 billion by 2025, according to a new report conducted by Grand View Research, Inc. The surging acceptance in healthcare and aerospace & automobile component designing arenas is expected to impel the market growth. The increasing acceptance in the industrial manufacturing segment, specifically in metal processing and modelling procedures, i …
- ブロックチェーンデバイスの世界市場予測(~2024年)Blockchain devices market to grow at CAGR of 42.5% from 2019 to 2024The blockchain devices market is projected to grow from USD 218 million in 2019 to USD 1,285 million by 2024, at a CAGR of 42.5% from 2019 to 2024. Some of the major growth drivers for this market include increasing adoption of blockchain technology in retail & supply chain management, rising venture capital funding, and growing m …
- 医薬品のろ過の世界市場分析:製品別(メンブレンフィルター、プレフィルター・デプスメディア、カートリッジ・カプセル)、方法別(精密濾過、限外濾過)、用途別、オペレーション規模別、セグメント予測、2014-2025The global pharmaceutical filtration market is expected to reach USD 37.3 billion by the year 2025 growing at a CAGR of 12.1%, according to a new report by Grand View Research, Inc. The growing expansion of the biopharmaceutical industry have resulted in enormous growth of the market with new and more enhanced technologies being used to cater to the need of drug manufacturers. Increasing demand fo …
- 民間航空機用アビオニクスの世界市場2015-2019About Commercial Aircraft Avionics Systems Avionics are electronics systems used in aircraft for communication, navigation, and various other flight critical applications. Avionics are one of the most expensive and highly critical components in modern aircraft. Modern avionics also aid in improved navigation and routing, provide enhanced situational awareness to pilots, and improve the ATM process …
- インテリジェント仮想アシスタント(IVA)の世界市場分析:タイプ別(音声認識、テキスト – 音声認識)、サービス別(カスタマーサービス、マーケットアシスタント)、用途別(BFSI、自動車、IT・テレコム、小売、ヘルスケア、教育)、エンドユーザー別(中小企業、大企業、個人ユーザー)、セグメント予測The global Intelligent Virtual Assistant (IVA) market size is expected to reach USD 12.28 billion by 2024 according to a new report by Grand View Research, Inc. Demand for online self-service and growing need for self-reliance and rapid resolution of queries are expected to be the primary contributors to market growth. Online websites have become the preferred service channel for consumers gatheri …
- 機能性添加剤およびバリアコーティングの世界市場:抗酸化剤、UV安定剤、抗菌剤、ブロッキング防止剤、清澄剤、帯電防止剤、防曇剤、金属被覆コーティング、有機液体コーティング、無機液体コーティングThe market size of functional additives and barrier coatings is projected to reach USD 4.90 Billion by 2020, at a CAGR of 5.5% between 2015 and 2020. The increased use of packaging material, especially in Asia-Pacific, owing to the changing lifestyle, higher population, and rapid urbanization is one of the key factors driving the market. The pharmaceutical & healthcare segment is projected to be t …
- 世界の無機機能材料市場2015The Global Inorganic Functional Materials Industry Report 2015 is a professional and in-depth study on the current state of the Inorganic Functional Materials industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Inorganic Functional Materials market analysis is provided for the international markets inc …
- 世界の窒化ガリウム半導体デバイス市場動向(2012-2016)TechNavio's analysts forecast the Global Gallium Nitride Semiconductor Devices market to grow at a CAGR of 18 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high thermal conductivity of gallium nitride over other non-silicon substrates. The Global Gallium Nitride Semiconductor Devices market has also been witnessing the increasing preference for …
- 交通カードの世界市場2016-2020About the Transit Cards Market The increase in population and urbanization has resulted in the growing need for mobility. Public transportation has become the most preferred mode of transportation for people to avoid problems such as air pollution and traffic congestion. Traveling by buses, trains, and metros is often more comfortable, convenient, and cost-effective. To make traveling for people m …
- 無線周波数(RF)信号発生器の世界市場展望2017-20276According to Stratistics MRC, the Global Radio Frequency (RF) Signal Generator Market is accounted for $24.43 million in 2017 and is expected to reach $33.30 million by 2026 growing at a CAGR of 3.5% during the forecast period. Increasing demand for rental test equipment and rising interest in LTE-A in rural zones are some of the factors fuelling the market growth. However, large space requirement …
- 自動車用クラッチの世界市場展望2017-2026According to Stratistics MRC, the Global Automotive Clutch Market is accounted for $9119.14 million in 2017 and is expected to reach $18535.29 million by 2026 growing at a CAGR of 8.2% during the forecast period. Stringent emission norms, need for fuel efficiency as well as technological advancement such as the dual clutch transmission system are driving the market of Automotive Clutch Market. How …